Saunders and Walker Class Action Law Firm
Watch This Introductory Video to Saunders and Walker Law



Email Joe Saunders at Saunders and Walker

Xarelto Maker Made False Report to FDA

xarelto-lawsuitThe British Medical Journal, better known as the BMJ, is claiming that Janssen Pharmaceutical withheld key information to the US FDA prior to the pharmaceutical company’s drug approval by the FDA.

The false report may have led to the FDA approval of a drug used by thousands of patients and marketed on television by celebrities as a wonder drug.  

According to Drug Watch, “Janssen withheld data about problems with the INRation device from the U.S. Food and Drug Administration, the investigators said. The device monitored patients using warfarin during phase III of the ROCKET AF trial and may have compromised data and patient safety. The FDA used data in this trial to approve Xarelto, now one of the bestselling anticoagulants on the market. In 2015, the drug made close to $2 billion for J&J, according to company reports.”

Xarelto was approved by the FDA in July 2011 to treat patients with deep vein thrombosis in hip and knee replacement patients.  Xarelto was approved later that same year to prevent strokes in patients with a common type of abnormal heart rhythm.

Since its market debut, Xarelto’s manufacturers have been faced with more than 11,000 lawsuits filed as a result of complications from internal bleeding. The pharmaceutical company paid $650 million to resolve 4,000 lawsuits about bleeding in 2014.

The 2016 study conducted by David J. Graham and colleagues and published in JAMA Internal Medicine raises concern that Xarelto is associated with increased bleeding and mortality compared to Pradaxa in patients with atrial fibrillation (AF).

This suffering could have been avoided if the manufacturer of Xarelto had not withheld crucial clinical information in order to rush a bad drug to market to increase company profits.  Xarelto sales have been a windfall for the pharmaceutical company and its parent, Johnson & Johnson.  In 2015 alone, the drug made close to $2 billion in profits.  Of course, this was at the expense of the truth and the health and welfare of countless patients and doctors who have been duped into taking this drug by celebrity spokesmen paid by Janssen.

For help concerning a potential legal case against the manufacturers of Xarelto, contact Saunders & Walker today online.

Leave a reply

Fill out this form for a FREE, Immediate, Case Evaluation

Home Banner Form

  • This field is for validation purposes and should be left unchanged.

Saunders and Walker Class Action Law Firm

Call Us 24/7

Connect with us

  • facebook
  • youtube
  • LinkedIn

Saunders & Walker
3491 Gandy Blvd
Pinellas Park, FL 33781
Phone: (727) 579-4500
Phone: 1-800-748-7115

Click Here for Map